Patient-reported outcomes in palopegteriparatide-treated adults with hypoparathyroidism: PaTH Forward trial extension
Through week 110 of the PaTH Forward trial, PTH replacement therapy with palopegteriparatide was associated with significant improvements in disease-specific symptoms and impacts on daily functioning and well-being, as well as general health-related QoL.
Authors
- Elena Tsourdi (ORCID: https://orcid.org/0000-0002-9582-1906)
- Kathryn M. Pfeiffer (ORCID: https://orcid.org/0000-0003-2186-6340)
- Aimee D Shu (ORCID: https://orcid.org/0000-0003-1801-5289)
- Lori McLeod (ORCID: https://orcid.org/0000-0002-7837-8033)
- Tanja Sikjær (ORCID: https://orcid.org/0000-0002-9074-9570)
- Meryl Brod (ORCID: https://orcid.org/0000-0002-0663-5838)
- Peter Schwarz (ORCID: https://orcid.org/0000-0002-0483-8594)
- Wahidullah Noori
- Filomena Cetani (ORCID: https://orcid.org/0000-0003-2558-9547)
- Aliya Khan (ORCID: https://orcid.org/0000-0003-3733-8956)
- Uberto Pagotto (ORCID: https://orcid.org/0000-0003-4182-3110)
- Andrea Palermo
- Alden Smith (ORCID: https://orcid.org/0000-0003-1582-534X)
- Tamara Vokes (ORCID: https://orcid.org/0000-0003-1628-9673)
- Mishaela R. Rubin
- Carol Zhao
Institutions
- University of Pisa (IT)
- Università Campus Bio-Medico (IT)
- Aarhus University Hospital (DK)
- Copenhagen University Hospital (DK)
- Rigshospitalet (DK)
- University of Chicago (US)
- Brod Group (US)
- Ascendis Pharma (Denmark) (DK)
- Azienda USL di Bologna (IT)
- RTI Health Solutions (US)
- Campus Bio Medico University Hospital (IT)
- Columbia University (US)
- Technische Universität Dresden (DE)
- University of Bologna (IT)
- McMaster University (CA)
Publication Details
- Journal
- The Journal of Clinical Endocrinology & Metabolism
- Published
- 2025-12-06
- DOI
- https://doi.org/10.1210/clinem/dgaf653
- Primary Topic
- Thyroid and Parathyroid Surgery
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Amgen
- Eli Lilly and Company
- AstraZeneca
- Alexion Pharmaceuticals
- Novo Nordisk
- Chugai Pharmaceutical